Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Bienvenu
Gerard Bienvenu, Viuz-En-Sallaz FR
| Patent application number | Description | Published |
|---|---|---|
| 20120121998 | METHOD FOR CO-GENERATION OF ELECTRIC ENERGY AND HYDROGEN - A method for simultaneous co-generation of electric energy and hydrogen by totally electrochemical means which includes an electricity storage phase by electrolysis of an electrolysable metal solution and formation of a hydrogen-electrolysable metal battery cell and, an electricity recovery and hydrogen generation phase by operation of said battery cell. The electrolysable metal is chosen from zinc, nickel and manganese. | 05-17-2012 |
Gérard Bienvenu, Viuz-En-Salaz FR
| Patent application number | Description | Published |
|---|---|---|
| 20120061397 | Adiabatic Tank For Metal Hydride - The invention relates to a safe hydrogen-storing tank that is easy to manufacture and enables the quick kinetic absorption of hydrogen, which reduces the variations in volume and has a low cost in terms of material and energy. The invention has the aim of providing a tank for storing hydrogen, including a hydrogen inlet ( | 03-15-2012 |
Jean-Francois Bienvenu, Laval CA
| Patent application number | Description | Published |
|---|---|---|
| 20090068169 | 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use - The present invention describes new compounds which are useful for binding to the tail or Fc portion of immunoglobulins and so have utility in those applications which require the non-covalent binding interaction of a molecule with the Fc portion of immunoglobulins. Such applications include the detection and purification of immunoglobulins as well as the treatment of certain autoimmune diseases. | 03-12-2009 |
Jean-François Bienvenu, Quebec CA
| Patent application number | Description | Published |
|---|---|---|
| 20120088784 | Substituted Aromatic Compounds and Pharmaceutical Uses thereof - The present invention relates to substituted aromatic compounds of Formula I and their pharmaceutical uses. Particular aspects of the invention relate to the use of those compounds in the prevention and/or treatment of various diseases and conditions in subjects, including the prevention or treatment of (i) blood disorders, (ii) renal disorders, a nephropathies, or renal disorder complications; (iii) inflammatory-related diseases; and/or (iv) oxidative stress related disorders. | 04-12-2012 |
| 20120095102 | Salts of 3-Pentylphenylacetic Acid and Pharmaceutical Uses Thereof - The present invention relates to salts of 3-pentylphenylacetic acid and their pharmaceutical uses. Particular aspects of the invention relate to the use of those salts in the prevention and/or treatment of various diseases and conditions in subjects, including the prevention and treatment of (i) blood disorders, (ii) renal disorders and renal disorder complications; (iii) inflammatory-related diseases; and/or (iv) oxidative stress related disorders. | 04-19-2012 |
Michael E. Bienvenu, Cary, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20080262780 | Paving-Related Measuring Device Incorporating a Computer Device and Communication Element Therebetween and Associated Method - A system for determining a property of a paving-related material is provided. Such a system comprises a measuring device for selectively and directly measuring the property. A computer device is capable of executing a software program product and communicating with the measuring device. The computer device directs the measuring device to measure the property of the paving-related material according to a parameter determined by the software program product, and to receive data comprising the measured property from the measuring device. A communication element operably engaged between the measuring device and the computer device allows communication therebetween. The communication element is configured to allow the computer device to be spaced apart from the measuring device, thereby allowing the computer device to be prepared, to include the parameter and to manipulate the data, in spaced apart relation with respect to the measuring device. An associated method is also provided. | 10-23-2008 |
Philippe Bienvenu, Allauch FR
| Patent application number | Description | Published |
|---|---|---|
| 20120081092 | LOW ELECTROMAGNETIC EMISSION DRIVER - The disclosure concerns circuitry for controlling a power transistor of a drive circuit arranged to drive an electrical component, the circuitry comprising: a variable current source adapted to set the level of a current for charging a control terminal of said power transistor; and a control circuit adapted to control said variable current source in a continuous manner based on a feedback voltage. | 04-05-2012 |
Ryan Bienvenu, Santa Rosa, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110202124 | Apparatus and Methods for Creating a Venous Valve from Autologous Tissue - An implantable prosthesis for percutaneous placement within a vein that forces opposing portions of the vessel wall of a vein together to create a new valve of autologous vein tissue to be operable to alternate between a valve closed configuration and a valve open configuration. When in a preset closed configuration, the implantable prosthesis pushes or pulls portions of the vessel wall of the vein together to substantially close the vein lumen and prevent retrograde blood flow from backflowing through the new valve in the valve closed configuration. The implantable prosthesis has leg portions that may be pushed apart in response to antegrade blood flow through the vein to allow the new valve to achieve the valve open configuration. | 08-18-2011 |
| 20110202127 | Apparatus and Methods for Creating a Venous Valve From Autologous Tissue - An implantable prosthesis for percutaneous placement within a vein that forces opposing portions of the vessel wall of a vein together to create a new valve of autologous vein tissue to be operable to alternate between a valve closed configuration and a valve open configuration. When in a preset closed configuration, the implantable prosthesis pushes or pulls portions of the vessel wall of the vein together to substantially close the vein lumen and prevent retrograde blood flow from backflowing through the new valve in the valve closed configuration. The implantable prosthesis has leg portions that may be pushed apart in response to antegrade blood flow through the vein to allow the new valve to achieve the valve open configuration. | 08-18-2011 |
| 20120067008 | Method of Forming a Drug-Eluting Medical Device - A method of forming a stent includes the steps of forming an elongated composite member or plurality of elongated composite members into a stent pattern having struts interconnected by crowns, the composite member including an outer member and a core member. Openings are formed through the outer member of the composite member. The composite member is processed to remove the core member from at least a plurality of the struts of the stent without adversely affecting the outer member and such that the core member is not removed from at least a plurality of the crowns of the stent, thereby leaving the outer member with a lumen in at least a plurality of the struts and the outer member with the core member in at least a plurality of the crowns. The lumens may then be filled with a biologically or pharmacologically active substance. | 03-22-2012 |
| 20120067103 | Method of Forming a Drug-Eluting Medical Device - A method of forming a stent includes the steps of forming a composite member into a stent pattern, forming openings through an outer member of the composite member, processing the composite member to remove a portion of the composite member without adversely affecting the outer member, and swaging the outer member to create a plurality of lumens. The composite member may be formed of an outer member with an hourglass-shaped inner member, wherein the processing step removes the inner member and the swaging step forms two lumens from the hourglass shaped cavity. The composite member may be formed of an outer member, an inner member, and an intermediate member, wherein the processing step removes the intermediate member and the swaging step presses portions of the outer member into contact with the inner member to form two lumens separated by the inner member. | 03-22-2012 |
| 20120071961 | Stent With Hollow Drug-Eluting Elements - A stent includes a plurality of cylindrical elements joined along a common longitudinal axis to form a tube. The cylindrical elements include struts joined by crowns. Hollow, drug-eluting elements are disposed between adjacent cylindrical elements and connect adjacent cylindrical elements to each other. A therapeutic substance fills the lumen of the drug-eluting elements, and openings in the walls of the drug-eluting elements allow elution of therapeutic substance from the lumen for treatment of a vessel. | 03-22-2012 |